Drug Type Small molecule drug |
Synonyms PLX 300, PLX300 |
Target |
Action agonists, inhibitors |
Mechanism PPARα agonists(Peroxisome proliferator-activated receptor α agonists), Apoptosis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States), Rare Pediatric Disease (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Niemann-Pick Disease, Type A | Phase 1 | United States | 18 Dec 2020 | |
Leukodystrophy, Globoid Cell | Phase 1 | United States | 14 Nov 2020 | |
Niemann-Pick Disease, Type B | Preclinical | United States | 10 Nov 2020 | |
Sandhoff Disease | Preclinical | United States | 10 Nov 2020 | |
Tay-Sachs Disease | Preclinical | United States | 04 Nov 2020 |